Our results revealed that CPX activated PERK-dependent ER stress and UPRER in NSCLC cells, and the CPX treatment dramatically increases the phosphorylation at Threonine 980 of PERK and Serine 51 of eIF2α, respectively, both in dose-dependent manners (Fig. 5A). Here, EIF2A is linked to non-small cell lung carcinoma.